Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Tofacitinib citrate |
Is a |
False |
Tofacitinib (substance) |
Inferred relationship |
Some |
|
Product containing tofacitinib (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Tofacitinib (substance) |
Inferred relationship |
Some |
1 |
Tofacitinib therapy (procedure) |
Direct substance |
True |
Tofacitinib (substance) |
Inferred relationship |
Some |
2 |
Tofacitinib citrate |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Tofacitinib (substance) |
Inferred relationship |
Some |
|
Tofacitinib-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Tofacitinib (substance) |
Inferred relationship |
Some |
1 |
Product containing only tofacitinib (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Tofacitinib (substance) |
Inferred relationship |
Some |
1 |
Tofacitinib only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Tofacitinib (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely tofacitinib (as tofacitinib citrate) 5 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Tofacitinib (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely tofacitinib (as tofacitinib citrate) 11 milligram/1 each prolonged-release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Tofacitinib (substance) |
Inferred relationship |
Some |
1 |
Tofacitinib (as tofacitinib citrate) 10 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Tofacitinib (substance) |
Inferred relationship |
Some |
1 |
Tofacitinib (as tofacitinib citrate) 1 mg/mL oral solution |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Tofacitinib (substance) |
Inferred relationship |
Some |
1 |